Preclinical studies showed that blocking PI3K/mTOR with PF-04691502 can enhance TP53/p73 expression and significantly inhibit tumor growth in head and neck squamous cell carcinoma [139]. The gene discussed is PIK3CA; the disease is neoplasm.